As-needed albuterol-budesonide yields a lower risk for severe asthma exacerbation among patients with mild asthma, according ...

Findings from a first-of-its-kind virtual trial in pulmonary medicine, conducted at Rutgers and many other institutions, ...

As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations ...

A low-carbon version of a triple combination pMDI inhaler indicated for adults with moderate-to-severe COPD has been approved by the MHRA.

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society (ATS) 2025 International Conference.

For World Asthma Day, GINA released its 2025 guidelines update and joined in a campaign to make inhaled asthma therapies more ...

New findings suggest asthma may be reversible in some cases, offering hope for long-term remission and a shift in treatment ...

Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored ...

Australia’s new asthma guidelines warn against anyone with asthma – even those with infrequent symptoms – using only ...

By Sandra Agyeiwaa OTOOTrust Specialists Hospital, in partnership with AstraZeneca, has marked World Asthma Day 2025 with a ...

MONDAY, May 12, 2025 (HealthDay News) -- Young women taking the Pill might have an increased risk of asthma attacks, a new ...

and asthma. (Unsplash) Addressing these challenges calls for a patient-centric, simplified approach. Dr Namita Mittal said, “Using combination inhalers that reduce dosing frequency ...